La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

MedAvail Holdings Salute del bilancio

Salute finanziaria criteri di controllo 3/6

MedAvail Holdings ha un patrimonio netto totale di $23.0M e un debito totale di $1.5M, che porta il suo rapporto debito/patrimonio netto a 6.5%. Le sue attività totali e le sue passività totali sono rispettivamente $29.9M e $6.9M.

Informazioni chiave

6.5%

Rapporto debito/patrimonio netto

US$1.51m

Debito

Indice di copertura degli interessi	n/a
Contanti	US$14.36m
Patrimonio netto	US$23.05m
Totale passività	US$6.86m
Totale attività	US$29.91m

Aggiornamenti recenti sulla salute finanziaria

Recent updates

Slammed 31% MedAvail Holdings, Inc. (NASDAQ:MDVL) Screens Well Here But There Might Be A Catch

Aug 17

Is There An Opportunity With MedAvail Holdings, Inc's (NASDAQ:MDVL) 32% Undervaluation?

Feb 20

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( $27.0M ) di MDVL superano le sue passività a breve termine ( $4.2M ).

Passività a lungo termine: Le attività a breve termine di MDVL ( $27.0M ) superano le sue passività a lungo termine ( $2.7M ).

Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: MDVL ha più liquidità del suo debito totale.

Riduzione del debito: Dati insufficienti per determinare se il rapporto debito/patrimonio netto di MDVL si sia ridotto negli ultimi 5 anni.

Bilancio

Analisi della pista di contanti

Per le società che in passato sono state mediamente in perdita, valutiamo se hanno almeno un anno di liquidità.

Pista di liquidità stabile: MDVL ha meno di un anno di cash runway in base al suo attuale free cash flow.

Previsione Cash Runway: MDVL ha meno di un anno di liquidità disponibile se il flusso di cassa libero continua a ridursi ai tassi storici del 24.4 % ogni anno

MedAvail Holdings Salute del bilancio

Salute finanziaria criteri di controllo 3/6

Informazioni chiave

Aggiornamenti recenti sulla salute finanziaria

Nasdaq to Delist Common Stock of MedAvail Holdings

MedAvail Holdings, Inc. Filed for Bankruptcy

MedAvail Holdings, Inc. announced delayed 10-Q filing

MedAvail Announces 1-for-50 Reverse Stock Split to Regain Compliance with the Minimum Bid Price Requirement

MedAvail Holdings, Inc. announced delayed 10-Q filing

MedAvail Holdings Receives A Letter from Nasdaq Regarding Minimum Bid Price Requirement

Recent updates

MedAvail Holdings, Inc.(OTCPK:MDVL.Q) dropped from S&P TMI Index

MedAvail Holdings, Inc.(OTCPK:MDVL.Q) dropped from NASDAQ Composite Index

Nasdaq to Delist Common Stock of MedAvail Holdings

MedAvail Holdings, Inc. Filed for Bankruptcy

MedAvail Holdings, Inc. Announces Board of Directors Resignations

MedAvail Holdings, Inc. announced delayed 10-Q filing

Slammed 31% MedAvail Holdings, Inc. (NASDAQ:MDVL) Screens Well Here But There Might Be A Catch

High number of new and inexperienced directors

MedAvail Announces 1-for-50 Reverse Stock Split to Regain Compliance with the Minimum Bid Price Requirement

MedAvail Holdings, Inc. Reaffirms Earnings Guidance for the Full Year 2023

MedAvail Holdings, Inc. announced delayed 10-Q filing

Full year 2022 earnings: EPS exceeds analyst expectations

High number of new and inexperienced directors

Medavail Holdings, Inc. Announces Executive Resignations

German Dobson CVS, L.L.C., Garfield Beach CVS, L.L.C., Holiday CVS, L.L.C., Longs Drug Stores California, Inc. and Woodward Detroit CVS, L.L.C. entered into the asset purchase and sale agreement to acquire Pharmacy Assets of MedAvail Holdings, Inc. for $4.4 million.

Medavail Holdings, Inc. Initiates Reduction in Force

High number of new and inexperienced directors

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

MedAvail Holdings, Inc. Provides Revenue Guidance for the Full Year 2022

MedAvail Holdings Receives A Letter from Nasdaq Regarding Minimum Bid Price Requirement

MedAvail Holdings, Inc. to Report Q3, 2022 Results on Nov 10, 2022

Consensus estimates of losses per share improve by 31%

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

MedAvail Holdings, Inc. Provides Revenue Guidance for the Full Year 2022

MedAvail Holdings: More Stock Dilution Seems Inevitable And I'm Bearish

MedAvail Holdings, Inc. to Report Q2, 2022 Results on Aug 11, 2022

MedAvail Holdings, Inc.(NasdaqCM:MDVL) dropped from Russell 2000 Growth Index

Consensus forecasts updated

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

MedAvail Holdings, Inc., Annual General Meeting, Jun 14, 2022

Price target decreased to US$5.00

Less than half of directors are independent

Consensus estimates of losses per share improve by 22%

Price target increased to US$8.00

MedAvail Holdings, Inc announced that it expects to receive $50.04375 million in funding

Medavail Holdings, Inc Strengthens Leadership Team

MedAvail Holdings, Inc Provides Revenue Guidance for the Fourth Quarter and Full Year 2021

Price target decreased to US$7.50

Third quarter 2021 earnings released: US$0.34 loss per share (vs US$0.74 loss in 3Q 2020)

Consensus revenue estimates fall to US$21.1m

Some Analysts Just Cut Their MedAvail Holdings, Inc (NASDAQ:MDVL) Estimates

Second quarter 2021 earnings released: US$0.32 loss per share (vs US$4.11 loss in 2Q 2020)

Medavail Holdings, Inc Revises Revenue Guidance for the Full Year 2021

Calculating The Intrinsic Value Of MedAvail Holdings, Inc (NASDAQ:MDVL)

MedAvail Holdings, Inc Narrows Revenue Guidance for the Full Year of Fiscal 2021

Full year 2020 earnings released: US$0.84 loss per share (vs US$16.85 loss in FY 2019)

MedAvail Holdings, Inc to Report Q4, 2020 Results on Mar 30, 2021

Is There An Opportunity With MedAvail Holdings, Inc's (NASDAQ:MDVL) 32% Undervaluation?

MedAvail’s SpotRx Pharmacy and Cigna Medical Group Partner to Help Improve Medication Access in Phoenix

Analisi della posizione finanziaria

Storia e analisi del rapporto debito/patrimonio netto

Bilancio

Analisi della pista di contanti

Scoprire le aziende sane